Skip to content

Clinical trials

Central Nervous System Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20182
20191
20202
20211
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital3
GlaxoSmithKline2
4D Molecular Therapeutics1
AbbVie1
AstraZeneca1
Eli Lilly and Company1
Neuroscience Trials Australia1
Remedy Pharmaceuticals, Inc.1
Taichung Veterans General Hospital1
Taipei Veterans General Hospital, Taiwan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases13
Brain Diseases7
Nervous System Diseases7
Cerebrovascular Disorders6
Stroke5
Alzheimer Disease4
Dementia4
Mental Disorders4
Cardiovascular Diseases3
Neurodegenerative Diseases3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.